000			01810 a2200541 4500
005			20250518051311.0
264		0	_c20200717
008			202007s 0 0 eng d
022			_a1872-7492
024	7		_a10.1016/j.virusres.2019.197664 _2doi
040			_aNLM _beng _cNLM
100	1		_aLian, Jiangshan
245	0	0	_aProphylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus. _h[electronic resource]
260			_bVirus research _c09 2019
300			_a197664 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntitubercular Agents _xadverse effects
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aChemical and Drug Induced Liver Injury _xprevention & control
650	0	4	_aCoinfection _xmicrobiology
650	0	4	_aFemale
650	0	4	_aHepatitis B _xdrug therapy
650	0	4	_aHepatitis B virus
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLiver _xdrug effects
650	0	4	_aLiver Failure _xprevention & control
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycobacterium tuberculosis
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTuberculosis _xdrug therapy
650	0	4	_aYoung Adult
700	1		_aHu, Ping
700	1		_aLu, Yingfeng
700	1		_aLiu, Yueying
700	1		_aWang, Xiaoxiao
700	1		_aZhang, Yimin
700	1		_aJia, Hongyu
700	1		_aYang, Yida
773	0		_tVirus research _gvol. 270 _gp. 197664
856	4	0	_uhttps://doi.org/10.1016/j.virusres.2019.197664 _zAvailable from publisher's website
999			_c29910187 _d29910187